PSV359 Therapy

Lead-212 PSV359 · Perspective Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PSV359 Therapy, covering 2026-01-16 to 2026-01-16. Get the full timeline:

Most recent: Clinical Trial Update: Lead-212 PSV359 Therapy for Patients With Solid Tumors [Phase 1, Phase 2]